Thus, TGF-β is associated with the loss of CD103− CD39+ CD8+ T cells in the vicinity of cancer cells, and the formation of both CD103+ CD39+ and CD103+ CD39− CD8+ T cell subsets. This evidence concerns the gene ENTPD1 and cancer.